False Claims Act Settlements Involving Physician Practice Billing Patterns

FCA settlements against physician practices have entered a structural inflection point now, not a cyclical spike. DOJ announced FCA settlements and judgments that topped $6.8 billion in fiscal year 2025, the highest annual total in the statute's history, and most of that money came from healthcare matters. Total recoveries under the FCA since Congress strengthened the statute in 1986 have now surpassed tens of billions of dollars, and that total has compounded year over year.

Enforcement has reached this level because DOJ has rebuilt how it finds billing anomalies, and patterns that once sat buried in claims data for years are now visible almost as soon as they form. In fiscal year 2025, DOJ opened 401 government-initiated investigations independent of any whistleblower, built entirely from data analysis. That number marks a shift in how cases originate: the government is no longer mostly waiting for someone inside a practice to come forward.

In June 2025, DOJ announced the creation of a Health Care Fraud Data Fusion Center, joining the Criminal Division, HHS-OIG, the FBI, and other federal agencies around coordinated data analysis meant to break down the information silos that used to keep one agency's claims data separate from another's. That is a permanent piece of federal infrastructure, not a temporary task force assembled to clear a backlog. HHS has separately announced plans to deploy AI tools to detect Medicare and Medicaid fraud, and CMS has proposed expanding its fraud prevention capabilities well beyond what they can do now.

Put those pieces together: billing patterns that would have gone unnoticed five years ago, buried in the normal statistical noise of claims submission, now appear in automated analysis long before a patient complaint or a former employee ever picks up the phone. A practice's exposure no longer depends on whether anyone decides to report it. It depends on whether its claims data looks different from its peers.

From Billing Pattern to False Claims Act Case

A billing pattern becomes FCA liability when two things are true at once: a claim submitted to the government is false, and it was submitted knowingly. The second condition carries more weight than most practices assume, because "knowing" under the statute includes acting in deliberate ignorance of what a billing system is actually producing. A practice does not need to intend fraud to incur liability. It needs only to have failed to look closely at the claims going out the door.

The financial structure of the statute makes this a serious risk at volume. The FCA imposes civil penalties on a per-claim basis, and for a practice submitting thousands of claims a year, that per-claim exposure can dwarf the eventual settlement figure negotiated to resolve the matter. Settlements and court orders can also carry exclusion or debarment from Medicare, Medicaid, and other federal health care programs, an outcome that can end a practice's ability to operate at all, regardless of its size or reputation.

DOJ's position on the "knowing" standard is unambiguous: a practice is responsible for what its billing system generates, whether that system was built in-house or purchased from an outside vendor. A billing default that systematically produces a higher-paying code does not shift liability to the company that coded the software. The practice that submits the claim owns the output.

The pool of people who can trigger a case has also widened. Qui tam relators, meaning whistleblowers who file suit on the government's behalf and share in any recovery, can include former employees and billing staff, but increasingly include data-mining firms with no personal connection to the practice. A practice no longer needs a disgruntled insider for scrutiny to find it. If claims data shows statistical outliers, that can draw a government-initiated investigation on its own.

Settlement rarely closes the matter cleanly. HHS-OIG can require a Corporate Integrity Agreement if it decides not to pursue exclusion, and for a physician practice, that agreement usually runs three years. It usually requires quarterly review by an Independent Review Organization of the practice's coding, billing, and claims submission, along with a compliance officer, written policies, internal audits, a code of conduct, and ongoing staff training. Beyond that operational burden, DOJ names practices that settle FCA allegations directly in its press releases, so a reputational cost lands apart from any dollar figure in the settlement.

Upcoding through EHR automation: the Vohra wound care case

The most dangerous form of upcoding in a physician practice rarely comes from a single physician who decides, claim by claim, to bill a higher code. It involves a billing or EHR system built to make that choice automatically, across thousands of encounters, over years, so that the pattern stays invisible to the practice until government data analysis uncovers it from the outside.

The government's case against Vohra Wound Physicians Management and its founder, Dr. Ameet Vohra, lays out that mechanism in detail. DOJ alleged that Vohra developed a proprietary EMR programmed to bill certain non-surgical procedures as if they were surgical. The system limited what clinical data a physician could enter, forced selection from a set of pre-populated drop-down options, and automatically inserted language into patient charges that read like specific clinical observations but was, in fact, pre-programmed text generated regardless of what the physician actually observed.

The structural trap sat inside the software's workflow logic. If a physician documented any percentage of devitalized material in a wound bed, no matter how small, the EMR treated a debridement as mandatory. A physician who wanted to record that no debridement had occurred had to actively find and select a narrow "Reasons for No Debridement" option, and the system would not let the encounter documentation proceed without that step. Left on its default path, the software simply recorded a debridement, and recorded it at the most intensive and expensive level, excisional debridement, as the standard outcome.

That design produced a billing pattern in which, for nearly eight consecutive years, debridements across the practice were coded almost uniformly as the highest-intensity surgical category. Dr. Vohra and his companies agreed to pay $45 million to resolve the allegations that resulted. No whistleblower had to flag the pattern, because no practice's debridement mix should look that uniform across eight years of real clinical variation, so claims data showed it on its own.

Liability in that case attached to Vohra, not to the company that built the EMR. That outcome illustrates DOJ's position concretely: a practice is responsible for what its software produces, whatever its origin. If you run an EHR or billing system, you should be able to answer one question. Does that system carry defaults, auto-populated fields, or workflow constraints that push documentation toward a higher-intensity code because it is the path of least resistance? A physician who has never reviewed those defaults is still the one who carries the liability for what the system generates on their behalf.

The pattern is not confined to wound care. In 2024, sixteen cardiology practices across 12 states agreed to pay a combined $17,761,564 to resolve claims that they had inflated the acquisition costs of diagnostic radiopharmaceuticals. The billing mechanism differed from Vohra's EMR defaults, but the underlying structure was the same: a systematic decision applied uniformly across a practice population, invisible until claims data flagged the outlier across more than a dozen practices at once.

Medically unnecessary procedures: how documentation mismatches generate claims exposure

Medically unnecessary procedure cases almost never turn on whether a procedure should have happened. They turn on whether the clinical record was built to make an unnecessary procedure look justified, which makes the quality of a practice's documentation a legal instrument in its own right, not just a clinical formality.

An Arizona cardiology group and three of its physicians agreed in March 2026 to pay a substantial sum resolving allegations that they performed and billed for medically unnecessary vein ablations. DOJ alleged the physicians made the procedures appear justified by incorrectly measuring or documenting the medical indicators, patient symptoms, and conservative therapy attempts that are supposed to precede a procedure of that kind. Advanced Urology, its affiliated companies, and Dr. Jitesh Patel agreed in April 2026 to pay $14 million over urological and diagnostic procedures that DOJ alleged were medically unnecessary or never performed at all, including permanent nerve-stimulator implants placed without first determining whether the patient stood to benefit, and billing for a more complex procedure, DVIU, when the physician had actually performed a simpler urethra dilation.

Serrano Kidney & Vascular Access Center and Dr. Feliciano Serrano agreed in May 2026 to pay more than $6.73 million over medically unnecessary vascular interventional procedures performed on 20 Medicare beneficiaries. Assistant Attorney General Brett A. Shumate of the Justice Department's Civil Division said, "Physicians should not be performing and billing for unnecessary and excessive medical interventions. False documentation of symptoms compromises the integrity of our federal health care programs and the well-being of beneficiaries." First Assistant U.S. Attorney Bill A. Essayli for the Central District of California added, "This settlement sends a clear message to physicians that the United States will zealously pursue appropriate action against those who submit false claims for taxpayer funds." In January 2026, five Florida ophthalmology practices agreed to pay nearly $6 million over unnecessary trans-cranial doppler ultrasounds tied to a kickback arrangement with a third-party testing company, and that case shows how often unnecessary-service allegations and kickback allegations occur together in the same investigation.

Lined up together, these cases share a structure. The procedures cluster around a specific physician or practice rather than distributing randomly across a patient population. Medical indicators get documented at exactly the threshold level needed to justify the procedure, and that repeats across patient after patient. Attempts at conservative therapy get logged without any credible clinical detail behind them. Each of those features is a statistical anomaly, and claims and medical record data show it well before a human investigator reads a single chart.

If a practice performs a given procedure at a rate meaningfully higher than its specialty peers, or its records show an unusually high share of patients documented at exactly the clinical threshold that justifies that procedure, it matches the statistical profile DOJ's analytics are built to find. The Advanced Urology case adds a further layer: billing for a procedure that never happened is a factual falsity claim, and it occurs alongside unnecessary-care allegations in several of these cases.

Kickback arrangements embedded in practice billing operations

Kickback cases brought against physician practices are, at their core, billing cases. The underlying financial arrangement usually starts in a referral relationship, but it becomes visible to investigators through the claims data it produces: unusual testing volumes, duplicate billing structures between two entities for the same service, or compensation tied to referral volume that outpaces any reasonable market rate.

Atlanta Gastroenterology Associates agreed in February 2026 to pay $4.75 million resolving allegations that it received kickbacks in exchange for patient referrals and billed for medically unnecessary testing. DOJ alleged the practice let an outside pathology laboratory set up and run a limited-capacity lab on the practice's own premises, in exchange for the practice's commitment to refer its patients there exclusively. Medicare then received two separate bills for the same slide: the practice billed for the technical component of preparing it, and the laboratory billed separately for interpreting it. That dual-billing structure, tied to an exclusive referral commitment, is what converted a referral relationship into a billing pattern a claims analysis could detect.

A mobile PET scan company agreed to pay a substantial sum resolving allegations that it paid referring cardiologists above-market "supervision" fees as inducements for referrals, running from September 2016 to January 2025. The arrangement was built to resemble ordinary professional compensation, but the size of the fee relative to the actual supervision work performed is what created the exposure. A fee that pays far more than the underlying work justifies stops functioning as compensation and starts functioning as a referral payment, and claims and payment data can expose that distinction.

The in-house ancillary services model keeps recurring across these cases for a specific structural reason: a laboratory, imaging service, or diagnostic capability sitting inside or next to a practice, combined with exclusive or near-exclusive referral patterns from that practice's own physicians, produces the exact profile DOJ scrutinizes. Any practice receiving fee arrangements from an outside vendor or service company, whether structured as supervision fees, medical director stipends, or administrative payments, should weigh whether that compensation is proportionate to the services actually rendered or whether it functions, in substance, as payment for referrals.

Diagnosis code inflation in risk-adjusted programs: the highest-dollar exposure vector

Diagnosis code inflation tied to risk-adjustment programs has become the single largest source of FCA recoveries in the health care space, and physician practices now carry exposure in two distinct roles. A practice can be exposed directly, as the entity submitting diagnosis codes that overstate a patient's clinical complexity. A practice can also be exposed indirectly, as a downstream participant in documentation schemes that risk-bearing entities design and run, often through chart-review vendors, coding software, or incentive structures that encourage physicians to document conditions more severely than the clinical picture supports.

Risk-adjustment payment models pay plans and providers more when patients are sicker, so the diagnosis codes submitted for a patient directly set what the government pays for that patient's care. A code inflated beyond what the medical record supports does not just misrepresent a single encounter. It distorts a risk score that follows the patient and the plan for the length of a payment year. These cases therefore tend to produce recoveries far larger than a single-practice billing dispute.

For a physician practice, the exposure in this category often begins outside the practice's own walls, inside a plan's coding software, a vendor's chart-review recommendations, or a financial incentive tied to how thoroughly a condition gets documented. A physician who accepts a suggested diagnosis code without verifying it against the actual clinical findings in the chart is participating in exactly the kind of documentation mismatch that has made this category the highest-dollar area of FCA enforcement now facing the physician practice community.